Atlas Trials

Ovarian Serous Tumor

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Ovarian Serous Tumor

RecordFirmDate
Auranofin and Sirolimus in Treating Participants With Ovarian Cancer (NCT03456700)Mayo Clinic2018-03-30
Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT03685695)Roswell Park Cancer Institute2017-06-27
Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT02595892)National Cancer Institute (NCI)2016-08-25
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02446600)National Cancer Institute (NCI)2016-03-28
Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer (NCT02627430)National Cancer Institute (NCI)2016-03-01
Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer (NCT02520115)Barbara Ann Karmanos Cancer Institute2015-08-01

Track Ovarian Serous Tumor automatically

Every clearance here is in the API, with alerts when new ones post.